Zongmei Zhou
YOU?
Author Swipe
View article: Port green investment strategy under government subsidization and regulation policy
Port green investment strategy under government subsidization and regulation policy Open
The greener port has become an important goal for the maritime industry. This paper developed an economic model to discuss how the investment effectiveness and two commonly used governmental policies (regulation and subsidy policies) affec…
View article: A nomogram for predicting the risk of chemoradiotherapy-associated thrombocytopenia in patients with esophageal cancer: a real-world cohort study
A nomogram for predicting the risk of chemoradiotherapy-associated thrombocytopenia in patients with esophageal cancer: a real-world cohort study Open
Background: Thrombocytopenia is a common hematological toxicity in esophageal cancer (EC) patients receiving radiation therapy. Objectives: The purpose of this study was to construct and validate a nomogram for predicting the incidence of …
View article: Definitive chemoradiotherapy combined with anti-PD-1 immunotherapy for inoperable esophageal squamous cell carcinoma: a multicenter real-world study
Definitive chemoradiotherapy combined with anti-PD-1 immunotherapy for inoperable esophageal squamous cell carcinoma: a multicenter real-world study Open
Trial no. NCT04821778 registered in ClinicalTrials.gov.
View article: Impact of gut microbiota on colorectal anastomotic healing (Review)
Impact of gut microbiota on colorectal anastomotic healing (Review) Open
Intestinal anastomosis is a critical procedure in both emergency and elective surgeries to maintain intestinal continuity. However, the incidence of anastomotic leakage (AL) has recently increased, reaching up to 20%, imposing major clinic…
View article: Multi-modal radiomics features to predict overall survival of locally advanced esophageal cancer after definitive chemoradiotherapy
Multi-modal radiomics features to predict overall survival of locally advanced esophageal cancer after definitive chemoradiotherapy Open
The hybrid radiomics-based model demontrated the best performance of predicting 2-year OS and can differentiate the high-risk and low-risk patients.
View article: Survival and Perioperative Outcomes After Addition of Immunotherapy to Neoadjuvant Chemoradiotherapy for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma
Survival and Perioperative Outcomes After Addition of Immunotherapy to Neoadjuvant Chemoradiotherapy for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma Open
Background Currently, neoadjuvant chemoradiotherapy combined with immunotherapy (NCRI) for patients with locally advanced esophageal squamous cell carcinoma (ESCC) is attracting attention. The purpose of this study was to compare the surgi…
View article: Combination of Metabolite Analysis and Network Pharmacology to Explore the Potential Anticough Mechanism of Protopine—A Marker in Zhi‐Ke‐Bao Tablets
Combination of Metabolite Analysis and Network Pharmacology to Explore the Potential Anticough Mechanism of Protopine—A Marker in Zhi‐Ke‐Bao Tablets Open
Rationale Protopine, an active alkaloid in Papaver somniferum L., was abundant in a well‐known anticough traditional Chinese medicine preparation—Zhi‐Ke‐Bao tablets. Till now, the metabolism feature and anticough mechanism of protopine hav…
View article: Multi-Centered Pre-Treatment CT-Based Radiomics Features to Predict Locoregional Recurrence of Locally Advanced Esophageal Cancer After Definitive Chemoradiotherapy
Multi-Centered Pre-Treatment CT-Based Radiomics Features to Predict Locoregional Recurrence of Locally Advanced Esophageal Cancer After Definitive Chemoradiotherapy Open
Purpose: We constructed a prediction model to predict a 2-year locoregional recurrence based on the clinical features and radiomic features extracted from the machine learning method using computed tomography (CT) before definite chemoradi…
View article: Current status and future development direction of treatment for essential tremor
Current status and future development direction of treatment for essential tremor Open
Essential tremor (ET) is a common movement disorder that continues to increase in prevalence. Currently used drugs such as propranolol and primidone have limited efficacy and are associated with a high number of side effects. For individua…
View article: Multi-centered Pre-treatment CT Based Radiomics Features to Predict Locoregional Recurrence of Locally Advanced Esophageal Cancer After Definitive Chemoradiotherapy
Multi-centered Pre-treatment CT Based Radiomics Features to Predict Locoregional Recurrence of Locally Advanced Esophageal Cancer After Definitive Chemoradiotherapy Open
Purpose We constructed a prediction model to predict 2-year locoregional recurrence based on the clinical features and radiomics features extracted from machine learning method using computed tomography (CT) before definite chemoradiothera…
View article: S-1-based concurrent chemoradiotherapy plus nimotuzumab in patients with locally advanced esophageal squamous cell carcinoma who failed neoadjuvant therapy: a real-world prospective study
S-1-based concurrent chemoradiotherapy plus nimotuzumab in patients with locally advanced esophageal squamous cell carcinoma who failed neoadjuvant therapy: a real-world prospective study Open
The study demonstrated the reasonable efficacy and promising safety of the S-1-Nimo-based CCRT in LA-ESCC patients with failure to neoadjuvant chemotherapy or chemoimmunotherapy.
View article: Implementing the optimized hippo‐avoidance prophylactic cranial irradiation for limited‐stage small cell lung cancer by tomotherapy and volumetric modulated arc therapy
Implementing the optimized hippo‐avoidance prophylactic cranial irradiation for limited‐stage small cell lung cancer by tomotherapy and volumetric modulated arc therapy Open
Background Hippo‐avoidance prophylactic cranial irradiation (HA‐PCI) requires a hippocampal avoidance zone expanded from hippocampus to ensure dose fall‐off and compensate for setup errors. Most studies recommend a 5‐mm margin, while it co…
View article: Conversion chemoradiotherapy combined with nab-paclitaxel plus cisplatin in patients with locally advanced borderline-resectable or unresectable esophageal squamous cell carcinoma: a phase i/ii prospective cohort study
Conversion chemoradiotherapy combined with nab-paclitaxel plus cisplatin in patients with locally advanced borderline-resectable or unresectable esophageal squamous cell carcinoma: a phase i/ii prospective cohort study Open
Background To evaluate the efficacy and safety of nab-paclitaxel plus cisplatin as the regimen of conversional chemoradiotherapy (cCRT) in locally advanced borderline resectable or unresectable esophageal squamous cell carcinoma (ESCC). Me…
View article: Hippocampal avoidance whole-brain radiotherapy with simultaneous integrated boost in lung cancer brain metastases and utility of the Hopkins verbal learning test for testing cognitive impairment in Chinese patients: a prospective phase II study
Hippocampal avoidance whole-brain radiotherapy with simultaneous integrated boost in lung cancer brain metastases and utility of the Hopkins verbal learning test for testing cognitive impairment in Chinese patients: a prospective phase II study Open
Background This study aimed to evaluate the efficiency of hippocampal avoidance whole-brain radiotherapy with a simultaneous integrated boost (HA-WBRT-SIB) treating brain metastases (BM) and utility of the Hopkins Verbal Learning Test-Revi…
View article: Multi-modal Radiomics Features to Predict Overall Survival of Locally Advanced Esophageal Cancer after Definitive Chemoradiotherapy
Multi-modal Radiomics Features to Predict Overall Survival of Locally Advanced Esophageal Cancer after Definitive Chemoradiotherapy Open
Purpose To establish prediction models to predict 2-year overall survival (OS) and stratify patients with different risks based on radiomics features extracted from magnetic resonance imaging (MRI) and computed tomography (CT) before defin…
View article: Conversion Chemoradiotherapy Combined with nab-paclitaxel plus Cisplatin in Patients with Locally Advanced Borderline-Resectable or Unresectable Esophageal Squamous Cell Carcinoma: a Phase Ⅰ/Ⅱ Prospective Cohort Study
Conversion Chemoradiotherapy Combined with nab-paclitaxel plus Cisplatin in Patients with Locally Advanced Borderline-Resectable or Unresectable Esophageal Squamous Cell Carcinoma: a Phase Ⅰ/Ⅱ Prospective Cohort Study Open
Background: To evaluate the efficacy and safety of nab-paclitaxel plus cisplatin as the regimen of conversional chemoradiotherapy (cCRT) in locally advanced borderline resectable or unresectable esophageal squamous cell carcinoma (ESCC). M…
View article: Induction PD-1 inhibitor toripalimab plus chemotherapy followed by concurrent chemoradiotherapy and consolidation toripalimab for bulky locally advanced non-small-cell lung cancer: protocol for a randomized phase II trial (InTRist study)
Induction PD-1 inhibitor toripalimab plus chemotherapy followed by concurrent chemoradiotherapy and consolidation toripalimab for bulky locally advanced non-small-cell lung cancer: protocol for a randomized phase II trial (InTRist study) Open
Background Immune checkpoint inhibitors (ICIs) have revolutionized the treatment landscape for locally advanced non-small-cell lung cancer (LA-NSCLC), whereas responses to anti-programmed cell death-1 (PD-1) or anti-programmed death-ligand…
View article: Effectiveness and safety of combined nimotuzumab and S-1 chemotherapy with concurrent radiotherapy for locally advanced esophageal cancer in malnourished and elderly patients: A prospective phase II study
Effectiveness and safety of combined nimotuzumab and S-1 chemotherapy with concurrent radiotherapy for locally advanced esophageal cancer in malnourished and elderly patients: A prospective phase II study Open
For malnourished or elderly patients with locally advanced esophageal cancer, radiotherapy combined with nimotuzumab and S-1 is effective and has a good safety profile.
View article: Efficacy and safety of definitive chemoradiotherapy with or without induction immune checkpoint inhibitors in patients with stage III non-small cell lung cancer
Efficacy and safety of definitive chemoradiotherapy with or without induction immune checkpoint inhibitors in patients with stage III non-small cell lung cancer Open
Background In the era of immunotherapy, the optimal combination of immune checkpoint inhibitors (ICIs) and chemoradiotherapy (CRT) for stage III non-small cell lung cancer (NSCLC) is not defined. The current study investigated the efficacy…
View article: PO25 MYH9 Related Disorder: A Benign R1933* MYH9 Mutation with Nephrology
PO25 MYH9 Related Disorder: A Benign R1933* MYH9 Mutation with Nephrology Open
Conclusion(s):In the experience of our center, although limited, we can conclude that in patients with stable platelet levels it is a useful drug but in the case of patients with oscillating levels it has not achieved better control of the…